High Dose Chemotherapy as Salvage Treatment for Unresectable Late Relapse Germ Cell Tumors

Journal of Urology

Volumn 184, Issue 1, 2010, Pages 168-173

  Lorch, Anja ^a   Rick, Oliver ^c   Wündisch, Thomas ^a   Hartmann, Jörg Thomas ^d   Bokemeyer, Carsten ^e   Beyer, Jörg ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b VIVANTES KLINIKUM AM URBAN   (Germany)

^c Klinik Reinhardshohe   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

drug therapy; germ cell and embryonal; neoplasms; recurrence; salvage therapy; testis

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IFOSFAMIDE;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG FATALITY; DRUG MEGADOSE; DRUG RESPONSE; FOLLOW UP; GERM CELL TUMOR; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TUMOR GROWTH; UNSPECIFIED SIDE EFFECT;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GERM CELL AND EMBRYONAL; PROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 77953231652     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.017     Document Type: Article

References (17)

1. Baniel J., Foster R.S., Gonin R., et al. Late relapse of testicular cancer. J Clin Oncol 13 (1995) 1170
2. Feldman D.R., Bosl G.J., Sheinfeld J., et al. Medical treatment of advanced testicular cancer. JAMA 299 (2008) 672
3. Oldenburg J., Martin J.M., and Fossa S.D. Late relapses of germ cell malignancies: incidence, management, and prognosis. J Clin Oncol 24 (2006) 5503
4. George D.W., Foster R.S., Hromas R.A., et al. Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol 21 (2003) 113
5. Gerl A., Clemm C., Schmeller N., et al. Late relapse of germ cell tumors after cisplatin-based chemotherapy. Ann Oncol 8 (1997) 41
6. Dieckmann K.P., Albers P., Classen J., et al. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases. J Urol 173 (2005) 824
7. Geldart T.R., Gale J., McKendrick J., et al. Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. BJU Int 98 (2006) 353
8. Ronnen E.A., Kondagunta G.V., Bacik J., et al. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy. J Clin Oncol 23 (2005) 6999
9. Sharp D.S., Carver B.S., Eggener S.E., et al. Clinical outcome and predictors of survival in late relapse of germ cell tumor. J Clin Oncol 26 (2008) 5524
10. Ehrlich Y., and Baniel J. Late relapse of testis cancer. Urol Clin North Am 34 (2007) 253
11. Lorch A., Kollmannsberger C., Hartmann J.T., et al. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group. J Clin Oncol 25 (2007) 2778
12. Oldenburg J., Alfsen G.C., Waehre H., et al. Late recurrences of germ cell malignancies: a population-based experience over three decades. Br J Cancer 94 (2006) 820
13. Shahidi M., Norman A.R., Dearnaley D.P., et al. Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management. Cancer 95 (2002) 520
14. Motzer R.J., Sheinfeld J., Mazumdar M., et al. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer. J Clin Oncol 18 (2000) 2413
15. Kondagunta G.V., Bacik J., Donadio A., et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol 23 (2005) 6549
16. Toner G.C. Clinical relevance of "late" in the management of late relapse after treatment for a germ cell tumor. J Clin Oncol 26 (2008) 5502
17. Kuczyk M.A., Bokemeyer C., Kollmannsberger C., et al. Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience. World J Urol 22 (2004) 55